In recurrent HNSCC, the expression of soluble major histocompatibility complex Class I chain-related peptide A and transforming growth factor-β is elevated, inhibiting NKG2D-dependent NK cell activation. Here, KLRK1 is linked to head and neck squamous cell carcinoma.